Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation TCT 2023

Patient Reported Outcomes in TTVI: Are They Meaningful?

Presenter: David Cohen

October 26, 2023

Presentation TCT 2023

We Need an RCT, and Here Is How I Would Like to Design It

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

Presenter: David Cohen

October 23, 2023

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

Presentation TVT 2022

Novel Digital Approaches to Aortic Valve Disease Screening: Introduction to the PREVUE VALVE Study

Presenter: David J. Cohen

June 09, 2022

Presentation TVT 2022

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Presenter: David Cohen

June 08, 2022

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, David J. Cohen

October 30, 2016

Advertisement

FDA Approval for TTVI

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Patient Reported Outcomes in TTVI: Are They Meaningful?

We Need an RCT, and Here Is How I Would Like to Design It

Importance of Patient Reported Outcomes

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Novel Digital Approaches to Aortic Valve Disease Screening: Introduction to the PREVUE VALVE Study

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Flash Debate: Counterpoint The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content